Results 251 to 260 of about 57,995 (263)
Some of the next articles are maybe not open access.

Physical-chemical characterization of octreotide encapsulated in commercial glucose-star PLGA microspheres.

Molecular Pharmaceutics, 2020
Sandostatin LAR is an injectable long-acting release (LAR) microsphere formulation for octreotide based on a biodegradeable glucose star copolymer of D,L-lactic and glycolic acids (PLGA-glu), which is primarily used for the treatment of patients with ...
Avital Beig   +8 more
semanticscholar   +1 more source

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Journal of Clinical Oncology, 2009
A. Rinke   +13 more
semanticscholar   +1 more source

Octreotide

Reactions weekly
Éó, H. J, Ofland
semanticscholar   +1 more source

Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study

Cancer Chemotherapy and Pharmacology, 2018
M. Pavel   +10 more
semanticscholar   +1 more source

Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors

Current Oncology Reports, 2016
V. Pokuri, M. Fong, R. Iyer
semanticscholar   +1 more source

Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices

ASAIO journal (1992), 2017
R. Malhotra   +7 more
semanticscholar   +1 more source

Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial

Journal of Gastrointestinal Surgery, 2015
Prakash Kurumboor   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy